Melanoma: open trials in Hungary

• NCT03340506

  Dabrafenib and/or Trametinib Rollover Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Orszagos Onkologiai Intezet, Budapest XII · University of Debrecen, Debrecen

  Registry updated 2026-11-03

• NCT06172478

  A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  Trial Treatment · Phase 2 · Daiichi Sankyo

  Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét

  Registry updated 2026-10-26

• NCT06697301

  Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

  Trial Treatment · Phase 2/3 · Eikon Therapeutics

  Orszagos Onkologiai Intezet, Budapest XII · University of Pecs, Pécs

  Registry updated 2026-10-06

• NCT04752826

  BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

  Trial Treatment · Phase 1/2 · BioInvent International AB

  Magyar Honvedseg Egeszsegugyi Kozpont, Budapest · PRA Health Sciences - Hungary, Budapest · Debreceni Egyetem Klinikai Kozpont, Debrecen

  Registry updated 2026-09-18

• NCT06112314

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  Trial Treatment · Phase 3 · Immunocore Ltd

  Orszagos Onkologiai Intezet (National Institute of Oncology), Budapest · Semmelweis Egyetem Általános Orvostudományi Kar, Budapest · Debreceni Egyetem-Klinikai Kozpont (DEKK), Debrecen · Pecsi Tudomanyegyetem (PTE) (University of Pecs), Pécs · Szegedi Tudomanyegyetem (University of Szeged), Szeged

  Registry updated 2026-02-25

• 2025-523620-44-02

  BudapestICIVasc: Cardiovascular side effects of immune checkpoint inhibitor oncological therapies and their monitoring in the context of onco-cardiology

  Trial Treatment · Phase 4 · Semmelweis University

  Semmelweis University, Budapest VIII

  Registry updated 2026-01-14

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error